ParkinsonFranceV1, Main, Curation, bibRecord, 002C69

Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

Identifieur interne : 002C69 ( Main/Curation ); précédent : 002C68; suivant : 002C70

Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

Auteurs : Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Claire Thalamas [France] ; Fabienne Ory [France] ; Isabelle Quelven [France] ; François Chollet [France] ; Jean Louis Montastruc [France] ; Olivier Rascol [France]

Source :

Movement Disorders [ 0885-3185 ] ; 2005-12.

RBID : ISTEX:0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29

English descriptors

KwdEn :
- Aged, Antiparkinson Agents (therapeutic use), Brain Mapping, Case-Control Studies, Cerebral Cortex (blood supply), Cerebrovascular Circulation (drug effects), H215O positron emission tomography, Humans, Levodopa (therapeutic use), Middle Aged, Pain (drug therapy), Pain (etiology), Pain Clinics, Pain Measurement (methods), Pain Threshold (drug effects), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson's disease, Positron-Emission Tomography, levodopa, pain threshold.
MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- blood supply : Cerebral Cortex.
- drug effects : Cerebrovascular Circulation, Pain Threshold.
- drug therapy : Pain, Parkinson Disease.
- etiology : Pain.
- methods : Pain Measurement.
- physiopathology : Parkinson Disease.
- Aged, Brain Mapping, Case-Control Studies, Humans, Middle Aged, Pain Clinics, Positron-Emission Tomography.

Abstract

Patients suffering from Parkinson's disease (PD) frequently experienced painful sensations that could be in part due to central modification of nociception. We compared pain threshold before and after administration of levodopa in PD patients and in controls, and investigated cerebral activity with positron emission tomography (PET) during experimental nociceptive stimulation. Pain threshold was determined using thermal stimulation during two randomized conditions: off and on. We performed H215O PET analysis of regional cerebral blood flow on subjects while they received alternate randomized noxious and innocuous stimuli during off and on conditions. In off condition, pain threshold in nine PD patients was significantly lower than in nine controls. Administration of levodopa significantly raised pain threshold in PD patients but not in controls. During off condition, there was a significant increase in pain‐induced activation in right insula and prefrontal and left anterior cingulate cortices in PD compared to control group. Levodopa significantly reduced pain‐induced activation in these areas in PD. This study shows that pain threshold is lower in PD patients but returns to normal ranges after levodopa administration. Moreover, PD patients have higher pain‐induced activation in nociceptive pathways, which can be reduced by levodopa. © 2005 Movement Disorder Society

Url:

https://api.istex.fr/document/0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29/fulltext/pdf

DOI: 10.1002/mds.20629

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001087
to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :001085
to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000B32
to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000F21
to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000E81
to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E81
to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000540
to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000540
to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000540
to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003040

Links to Exploration step

ISTEX:0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study</title>
<author><name sortKey="Brefel Ourbon, Christine" sort="Brefel Ourbon, Christine" uniqKey="Brefel Ourbon C" first="Christine" last="Brefel-Courbon">Christine Brefel-Courbon</name>
</author>
<author><name sortKey="Payoux, Pierre" sort="Payoux, Pierre" uniqKey="Payoux P" first="Pierre" last="Payoux">Pierre Payoux</name>
</author>
<author><name sortKey="Thalamas, Claire" sort="Thalamas, Claire" uniqKey="Thalamas C" first="Claire" last="Thalamas">Claire Thalamas</name>
</author>
<author><name sortKey="Ory, Fabienne" sort="Ory, Fabienne" uniqKey="Ory F" first="Fabienne" last="Ory">Fabienne Ory</name>
</author>
<author><name sortKey="Quelven, Isabelle" sort="Quelven, Isabelle" uniqKey="Quelven I" first="Isabelle" last="Quelven">Isabelle Quelven</name>
</author>
<author><name sortKey="Chollet, Francois" sort="Chollet, Francois" uniqKey="Chollet F" first="François" last="Chollet">François Chollet</name>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean Louis" last="Montastruc">Jean Louis Montastruc</name>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20629</idno>
<idno type="url">https://api.istex.fr/document/0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001087</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001087</idno>
<idno type="wicri:Area/Istex/Curation">001085</idno>
<idno type="wicri:Area/Istex/Checkpoint">000B32</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000B32</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Brefel Ourbon C:effect:of:levodopa</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16078219</idno>
<idno type="wicri:Area/PubMed/Corpus">000F21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F21</idno>
<idno type="wicri:Area/PubMed/Curation">000E81</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E81</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000E81</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E81</idno>
<idno type="wicri:Area/Ncbi/Merge">000540</idno>
<idno type="wicri:Area/Ncbi/Curation">000540</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000540</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Brefel Courbon C:effect:of:levodopa</idno>
<idno type="wicri:Area/Main/Merge">003040</idno>
<idno type="wicri:Area/Main/Curation">002C69</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study</title>
<author><name sortKey="Brefel Ourbon, Christine" sort="Brefel Ourbon, Christine" uniqKey="Brefel Ourbon C" first="Christine" last="Brefel-Courbon">Christine Brefel-Courbon</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Pharmacologie Clinique, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Purpan Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U455, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Pharmacologie Clinique, Faculté de Medecine, 37 Allées Jules Guesde, 31073 Toulouse Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Occitanie (région administrative)</region>
<region type="old region" nuts="2">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Payoux, Pierre" sort="Payoux, Pierre" uniqKey="Payoux P" first="Pierre" last="Payoux">Pierre Payoux</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U455, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Thalamas, Claire" sort="Thalamas, Claire" uniqKey="Thalamas C" first="Claire" last="Thalamas">Claire Thalamas</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Purpan Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ory, Fabienne" sort="Ory, Fabienne" uniqKey="Ory F" first="Fabienne" last="Ory">Fabienne Ory</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Purpan Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Quelven, Isabelle" sort="Quelven, Isabelle" uniqKey="Quelven I" first="Isabelle" last="Quelven">Isabelle Quelven</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Pharmacologie Clinique, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chollet, Francois" sort="Chollet, Francois" uniqKey="Chollet F" first="François" last="Chollet">François Chollet</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Neurologie, Purpan Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U455, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Montastruc, Jean Louis" sort="Montastruc, Jean Louis" uniqKey="Montastruc J" first="Jean Louis" last="Montastruc">Jean Louis Montastruc</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Pharmacologie Clinique, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Service de Pharmacologie Clinique, University Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U455, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Centre d'Investigation Clinique, Purpan Hospital, Toulouse</wicri:regionArea>
<placeName><region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-12">2005-12</date>
<biblScope unit="volume">20</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1557">1557</biblScope>
<biblScope unit="page" to="1563">1563</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29</idno>
<idno type="DOI">10.1002/mds.20629</idno>
<idno type="ArticleID">MDS20629</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Brain Mapping</term>
<term>Case-Control Studies</term>
<term>Cerebral Cortex (blood supply)</term>
<term>Cerebrovascular Circulation (drug effects)</term>
<term>H215O positron emission tomography</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Middle Aged</term>
<term>Pain (drug therapy)</term>
<term>Pain (etiology)</term>
<term>Pain Clinics</term>
<term>Pain Measurement (methods)</term>
<term>Pain Threshold (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson's disease</term>
<term>Positron-Emission Tomography</term>
<term>levodopa</term>
<term>pain threshold</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="blood supply" xml:lang="en"><term>Cerebral Cortex</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Cerebrovascular Circulation</term>
<term>Pain Threshold</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Pain</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pain</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Pain Measurement</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Brain Mapping</term>
<term>Case-Control Studies</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Pain Clinics</term>
<term>Positron-Emission Tomography</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Patients suffering from Parkinson's disease (PD) frequently experienced painful sensations that could be in part due to central modification of nociception. We compared pain threshold before and after administration of levodopa in PD patients and in controls, and investigated cerebral activity with positron emission tomography (PET) during experimental nociceptive stimulation. Pain threshold was determined using thermal stimulation during two randomized conditions: off and on. We performed H215O PET analysis of regional cerebral blood flow on subjects while they received alternate randomized noxious and innocuous stimuli during off and on conditions. In off condition, pain threshold in nine PD patients was significantly lower than in nine controls. Administration of levodopa significantly raised pain threshold in PD patients but not in controls. During off condition, there was a significant increase in pain‐induced activation in right insula and prefrontal and left anterior cingulate cortices in PD compared to control group. Levodopa significantly reduced pain‐induced activation in these areas in PD. This study shows that pain threshold is lower in PD patients but returns to normal ranges after levodopa administration. Moreover, PD patients have higher pain‐induced activation in nociceptive pathways, which can be reduced by levodopa. © 2005 Movement Disorder Society</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C69 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 002C69 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:0EA5DE53F8CADB17F74C9BC2F0A161EAF1810D29
   |texte=   Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

Effect of levodopa on pain threshold in Parkinson's disease: A clinical and positron emission tomography study

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri